Book contents
- Vaccines as Technology
- Vaccines as Technology
- Copyright page
- Contents
- Figures
- Acknowledgments
- Introduction
- 1 Vaccines as Instruments of Public Health
- 2 The Vaccine Development Ecosystem
- 3 Vaccine Development under Proprietary Paradigms
- 4 Access to Vaccine Technology
- 5 Aligning Vaccine Innovation with Public Health Needs
- 6 Vaccines of the Future
- Conclusion
- Index
3 - Vaccine Development under Proprietary Paradigms
Published online by Cambridge University Press: 07 April 2022
- Vaccines as Technology
- Vaccines as Technology
- Copyright page
- Contents
- Figures
- Acknowledgments
- Introduction
- 1 Vaccines as Instruments of Public Health
- 2 The Vaccine Development Ecosystem
- 3 Vaccine Development under Proprietary Paradigms
- 4 Access to Vaccine Technology
- 5 Aligning Vaccine Innovation with Public Health Needs
- 6 Vaccines of the Future
- Conclusion
- Index
Summary
Given the strong public health, societal, and economic benefits associated with the availability and widespread use of vaccines, an ideal scenario would dictate that vaccines needed to prevent and mitigate public health crises be treated as R&D priorities. Both domestic and international innovation policies would prioritize their development, and there would be mechanisms in place to ensure an equitable distribution of these vaccines. In practice, that is not the case.
Keywords
- Type
- Chapter
- Information
- Vaccines as TechnologyInnovation, Barriers, and the Public Health, pp. 56 - 92Publisher: Cambridge University PressPrint publication year: 2022